# FDA Inspection 1192276 - Octapharma S.A.S. - December 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-sas/396b52e7-9be7-4c70-b693-4ae5dc9fe859
Source feed: FDA_Inspections

> FDA Inspection 1192276 for Octapharma S.A.S. on December 06, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192276
- Company Name: Octapharma S.A.S.
- Inspection Date: 2022-12-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1297752 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/octapharma-sas/50d5a481-2788-48a4-8cd3-b0373bafd8a6)

Company: https://www.keypedia.com/companies/octapharma-sas/8e602de5-b511-4b74-aa10-2b4d1ef83dd5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d